Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comments on the ACD2 through web consultation
|
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comments on the ACD2 through web consultation
10 March 2011 (37.35 Kb 10 sec) |
This page was last updated: 08 March 2011